Brind.

Benzinga reported on the financial performance of Vertex Pharmaceuticals.

1 report, 1 independent Updated Jun 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Vertex Pharmaceuticals Benzinga

Keep exploring

The entities involved

Vertex Pharmaceuticals
American pharmaceutical company
- Financial firms, including RBC, TD Cowen, Leerink Partners, and Morgan Stanley, raised price targets and provided coverage for Vertex Pharmaceuticals.Tue 10:23
- CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.Sun 12:46
Benzinga
American news channel
- Benzinga reported on Cirrus Logic stock, which is listed on Nasdaq, following a price target cut by Susquehanna.Wed 14:50
- Benzinga generated content regarding the financial performance of Gilead Sciences on June 17, 2026.Tue 01:48

Related events

Benzinga Pro data reports on stock activity for Webull, a company related to the Nasdaq exchange.Jul 21
Benzinga reported on the earnings of Penguin Solutions.Jul 7
Benzinga reported that Mizuho cut its target price for a stock.Oct 7

Coverage

Newest first; wire copies grouped

Jun 12benzinga.com